Chronic myelomonocytic leukemia derived from a possible common progenitor of monocytes and natural killer cells

Leukemia and Lymphoma

Volumn 37, Issue 5-6, 2000, Pages 617-621

  Kojima, Hiroshi ^a   Bai, Amuguleng ^a   Mukai, Harumi Y ^a   Hori, Mitsuo ^a   Komeno, Takuya ^a   Hasegawa, Yuichi ^a   Ninomiya, Haruhiko ^a   Mori, Naoyoshi ^b   Nagasawa, Toshiro ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CD56; Chronic myelomonocytic leukemia; IL 2 receptor chain; NK activity

Indexed keywords

ACRACINOMYCIN; CD11B ANTIGEN; CD33 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CHROMIUM 51; COLONY STIMULATING FACTOR 1; CYTARABINE; ETOPOSIDE; GLYCOPROTEIN P 15095; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 2 RECEPTOR; UNCLASSIFIED DRUG; DIFFERENTIATION ANTIGEN; IL2RB PROTEIN, HUMAN; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN RECEPTOR; LEUKOCYTE ANTIGEN; TUMOR ANTIGEN; TUMOR MARKER;

AGED; ANTIGEN EXPRESSION; ARTICLE; CASE REPORT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN K 562; CHRONIC MYELOMONOCYTIC LEUKEMIA; HUMAN; HUMAN CELL; MONOCYTE; NATURAL KILLER CELL; PRIORITY JOURNAL; STEM CELL; CANCER STEM CELL; CELL LINEAGE; CHEMISTRY; CYTOTOXICITY; FATALITY; HEMATOPOIETIC STEM CELL; IMMUNOPHENOTYPING; MALE; PATHOLOGY;

AGED; ANTIGENS, CD; ANTIGENS, CD11B; ANTIGENS, CD11C; ANTIGENS, CD4; ANTIGENS, CD56; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ANTIGENS, NEOPLASM; CELL LINEAGE; CYTOTOXICITY, IMMUNOLOGIC; FATAL OUTCOME; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-2 RECEPTOR BETA SUBUNIT; K562 CELLS; KILLER CELLS, NATURAL; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MALE; MONOCYTES; RECEPTORS, INTERLEUKIN; TUMOR MARKERS, BIOLOGICAL; TUMOR STEM CELLS;

EID: 0034049581     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009058515     Document Type: Article

References (16)

1. Seymour, J. F., Pierce, S. A., Kantarjian, H. M., Keating, M. I. and Estey, E. H. (1994) Investigation of karyotypic, morphologic and clinical features in patients with acute myeloid leukemia blast cells expressing the neural cell adhesion molecule (CD56). Leukemia, 8, 823-826.
2. Thomas, X., Vila, L., Campos, L., Sabido, O. and Archimbaud, E. (1995) Expression of N-CAM (CD56) on acute leukemia cells: relationship with disease characteristics and outcome. Leuk Lymphoma, 19, 245-300.
3. Scott, A. A., Head, D. R., Kopecky, K. J., Appelbaum, F. R., Theil, K. S., Grever, M. R., Chen, I. M., Whittaker, M. H., Griffith, B. B., Licht, J. D., Waxman, S., Whalen, M. M., Bankhurst, A. D., Richter, L. C., Grogan, T. M. and Willman, C. L. (1994) HLA-DR-, CD33+, CD56+, CD16-myeloid/natural killer cell acute leukemia: A previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Blood, 84, 244-255.
4. Suzuki, R., Yamamoto, K., Seto, M., Kagami, Y., Ogura, M., Yatabe, Y., Suchi, T., Kodera, Y., Morishima, Y., Takahashi, T., Saito, H., Ueda, R. and Nakarnura S (1997) CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity. Blood, 90, 2417-2428.
5. Sanchez, M. J., Spits, H., Lanier, L. L. and Phillips, J. H. (1993) Human natural killer cell committed thymocytes and their relatioship to the T cell lineage. J Exp Med, 178, 1857-1866.
6. Sanchez, M. H., Muench, M. O., Roncarolo, M. G., Lanier, L. L. and Phillips, J. H. (1994) Identification of a common T / natural killer cell progenitor in human fetal thymus. J Exp Med, 180, 569-576.
7. Miller, J. S., Verfaillie, C. and McGlave, P. (1992) The generation of human natural killer cells from CD34+ / DR-primitive progenitors in long-term bone marrow culture. Blood, 80, 2182-2187.
8. Shibuya, A., Nagayoshi, K., Nakamura, K. and Nakauchi, H. (1995) Lymphokine requirement for the generation of natural killer cells from CD34+ hematopoietic progenitor cells. Blood, 85, 3538-3546.
9. Hasegawa, Y., Bai, A., Kojima, H., Komeno, T., Ninomiya, H. and Nagasawa, T. Priming effects of macrophage colony-stimulating factor on monocytic leukemia cells in combination with chemotherapy: induction of programmed cell death in vitro. Leuk Lymphoma (in press).
10. Bai, A., Kojima, H., Hori, M., Nara, N., Komeno, T., Hasegawa, Y., Ninomiya, H., Abe, T. and Nagasawa, T. (1999) Priming with G-CSF effectively enhanced low-dose Ara-C-induced in vivo apoptosis in myeloid leukemic cells. Exp Hematol, 27, 259-265.
11. Munn, D. H., Bree, A. G., Beall, A. C., Kaviani, M. D., Sabio, H., Schaub, R. G., Alpaugh, K., Weiner, L. M. and Goldman, S. J. (1996) Recombinant human macrophage colony-stimulating factor in nonhuman primates: selective expansion of a CD16+ monocyte subset with phenotypic similarity to primitive natural killer cells. Blood, 88, 1215-1224.
12. Fingerle, G., Pforte, A., Passlick, B., Blumenstein, M., Strobel, M. and Ziegler-Heitbrock, H. W. L. (1993) The novel subset of CD14+ / CD16+ blood monocytes is expanded in sepsis patients. Blood, 82, 3170-3176.
13. Locher, C., Vanham, G., Kestens, L., Kruger, M. Ceuppens, J. L., Vingerhoets, J. and Gigase, P. (1994) Expression patterns of Fc-gamma receptors. HLA-DR and selected adhesion molecules on monocytes from normal and HIV-infected individuals. Clin Exp Immunol, 98, 115-122.
14. Saleh, M. N., Goldman, S. J., LoBuglio, A. F., Beall, A. C., Sabio, H., McCord, M. C. Minasian, L., Alpaugh, R. K., Weiner, L. M. and Munn, D. H. (1995) CD16+ monocytes in patients with cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage colony-stimulating factor. Blood, 85, 2910-2917.
15. Li, H., Schwinzer, R., Baccarini, M. and Lohmann-Matthes, M.-L. Cooperative effects of colony-stimulating factor I and recomhinant interleukin 2 on proliferation and induction of cytotoxicity of macrophage precursors generated from mouse bone marrow cell cultures. J Exp Med, 169, 973-986.
16. Baccarini, M., Hao, L., Decker, T. and Lohmann-Matthes M.-L. (1988) Macrophage precursors as natural killer cells against tumor cells and microorganisms. Nat Immun Cell Growth Regul, 7, 316-327.